HIV Study Shows Gel Helps Prevent HIV & Herpes in Women | ThirdAge
Links shared publicly online about this topic.
- 1,008total visits
HIV Study Shows Gel Helps Prevent HIV & Herpes in Women | ThirdAge
View full resource at thirdage.com
Tags: HIV, STD, Herpes, Disease and Condition, Drug, Women's Health
Most Recently Shared on July 20, 2010 at 5:01 pm By:
HIV Study Shows Gel Helps Prevent HIV & Herpes in Women http://bit.ly/c8pMDD
HIV trial scrapped after gel found to be ineffective - Boston.com
boston.com — “In a major setback for AIDS prevention research, a clinical trial of a new vaginal gel supposed to reduce HIV infections has been suspended after studies showed it to be ineffective.” View full resource at boston.com
Most Recently Shared on November 28, 2011 at 11:21 pm By:
HIV trial scrapped after gel found to be ineffective: In a major setback for AIDS prevention research, a clinica... http://t.co/GlJFvSlK
HIV prevention trial ends in disappointment - chicagotribune.com
chicagotribune.com — “The microbicidal vaginal gel, tenofovir, does not prevent HIV infection from infected males to uninfected females, study shows.” View full resource at chicagotribune.com
Most Recently Shared on November 28, 2011 at 8:18 pm By:
HIV prevention trial ends in disappointment http://t.co/V5MHulpb
Oral tenofovir discontinued in HIV clinical trial
news-medical.net — “A large-scale clinical trial evaluating whether daily use of an oral tablet or vaginal gel containing antiretroviral drugs can prevent HIV infection in women is being modified because an interim review found that the study cannot show that one of the study products, oral tenofovir, marketed under the trade name Viread, is effective.” View full resource at news-medical.net
Most Recently Shared on September 29, 2011 at 2:20 pm By:
HIV/AIDS News: Oral tenofovir discontinued in HIV clinical trial: A large-scale clinical trial evaluating whethe... http://t.co/uQ64lH9y
Daily Dose of Gilead Drugs Prevent Heterosexual HIV Infection - Businessweek
businessweek.com — “A daily dose of drugs made by Gilead Sciences Inc. to treat HIV helped prevent infection in two studies that bolster earlier research showing existing medication can work to keep the disease from spreading.” View full resource at businessweek.com
Most Recently Shared on July 14, 2011 at 5:51 am By:
Drugs and Devices OW OW Health
Daily Dose of Gilead Drugs Prevent Heterosexual HIV Infection: A daily dose of drugs made by Gilead Sciences I... http://buswk.co/ncEvQT
Daily Dose of Gilead Drugs Prevent Heterosexual HIV Infection - Businessweek
businessweek.com — “A daily dose of drugs made by Gilead Sciences Inc. to treat HIV helped prevent infection in two studies that bolster earlier research showing existing medication can work to keep the disease from spreading.” View full resource at businessweek.com
Most Recently Shared on July 14, 2011 at 5:41 am By:
George Huba, Ph.D. Psychologist, PhD, and Doctor
Daily Dose of Gilead Drugs Prevent Heterosexual HIV Infection http://buswk.co/nFpBae
Pills Prevent H.I.V. Infection in 2 New Studies - NYTimes.com
nytimes.com — “Trials conducted in Africa were the first to show protection in heterosexuals whose partners had H.I.V.” View full resource at nytimes.com
Most Recently Shared on July 14, 2011 at 12:00 am By:
Colin Son Doctor, Medical Student, and Physician
Tenofovir and emtricitabine help prevent the transmission of HIV http://t.co/E4iEjdq
Community Involvement Raises HIV Testing Rates - NIH Research Matters - National Institutes of Health (NIH)
nih.gov — “A new study suggests that community-based programs can increase HIV testing in young people. Putting this type of strategy into practice might reduce risky behavior and help keep the spread of HIV in check.” View full resource at nih.gov
Most Recently Shared on May 17, 2011 at 1:29 pm By:
RT @graffhm: New NIH study shows community-based testing has HIV prevention impact http://1.usa.gov/k2LqJq
HIV prevention pill found to help men, not women - CBS News
cbsnews.com — “Researchers halt study on HIV prevention pill Truvada in African women after disappointing results show little success” View full resource at cbsnews.com
Most Recently Shared on April 18, 2011 at 2:58 pm By:
HIV prevention pill found to help men, not women: Researchers halt study on HIV prevention pill Truvada in Afric... http://bit.ly/dNpik3
Anti-AIDS gel shows promise
news-medical.net — “Dr. Ian McGowan, a professor of medicine at the University of Pittsburgh who is leading a second-phase study of the gel said, --These are early results, but [they] help set the stage for current and future trials of rectal microbicides and the development of a rectal-specific formulation of tenofovir gel.-- Researchers have focused on the use of microbicides such as tenofovir, as a preventive treatment to be used in vaginal sex. However, scientists think unprotected anal sex is much more risky.” View full resource at news-medical.net
Most Recently Shared on March 1, 2011 at 12:19 pm By:
HIV/AIDS News: Anti-AIDS gel shows promise: Dr. Ian McGowan, a professor of medicine at the University of Pittsb... http://bit.ly/g4c5bT
Steve Gibson on PrEP: Your Questions Answered - The Body
thebody.com — “A groundbreaking new study shows that antiretroviral drugs (ARVs), when taken correctly and offered along with condoms and counseling, could help to ...” View full resource at thebody.com
Most Recently Shared on February 1, 2011 at 1:02 am By:
Steve Gibson on PrEP: Your Questions Answered http://bit.ly/e425jn (From @sfaidsfound) #prevention #hiv #aids #prophylaxis
After HIV pill news, now comes the tricky part - CNN.com
cnn.com — “Last week, the National Institutes of Health announced a major advance in HIV prevention. The results of a study showed that a once-daily pill containing drugs used to treat HIV can also help prevent HIV infection -- a new approach called "pre-exposure prophylaxis."” View full resource at cnn.com
Most Recently Shared on December 1, 2010 at 8:49 pm By:
After HIV pill news, now comes the tricky part: Last week, the National Institutes of Health announced a major a... http://bit.ly/fEl2N9
After HIV pill news, now comes the tricky part - CNN.com
cnn.com — “Last week, the National Institutes of Health announced a major advance in HIV prevention. The results of a study showed that a once-daily pill containing drugs used to treat HIV can also help prevent HIV infection -- a new approach called "pre-exposure prophylaxis."” View full resource at cnn.com
Most Recently Shared on December 1, 2010 at 8:40 pm By:
After HIV pill news, the tricky part http://bit.ly/hxttXi
New drug research, incidence rates and Pope's comments brighten AIDS outlook
news-medical.net — “The Associated Press: "In the nearly 30 years the AIDS epidemic has raged, there has never been a more hopeful day than this. Three striking developments took place Tuesday: U.N. officials said new HIV cases are dropping dramatically worldwide. A study showed that a daily pill already on pharmacy shelves could help prevent new infections in gay men. And the pope opened the way for the use of condoms to prevent AIDS" (Marchione, 11/23).” View full resource at news-medical.net
Most Recently Shared on November 25, 2010 at 8:45 am By:
HIV/AIDS News: New drug research, incidence rates and Pope's comments brighten AIDS outlook: The Associated Pres... http://bit.ly/gDaNtj
Antiretroviral drugs can prevent HIV in men who have sex with men, study shows
sciencedaily.com — “The same drugs used for treating HIV can also help prevent infection, according to results from a new study of oral pre-exposure prohylaxis (PrEP) called iPrEx. The study, conducted with men who have sex with men, is a major boost to HIV prevention efforts but needs to be confirmed in other at-risk populations, say researchers.” View full resource at sciencedaily.com
Most Recently Shared on November 23, 2010 at 10:12 pm By:
Antiretroviral drugs can prevent HIV in men who have sex with men, study shows http://bit.ly/ev5QBY
MTN-007 phase trial evaluates rectal safety of vaginal microbicide in HIV transmission
news-medical.net — “Tenofovir gel, a vaginal microbicide that has shown promise for preventing HIV through vaginal sex, is being tested in a new trial looking at its safety and acceptability when used rectally. The results of the study, being led by the U.S. National Institutes of Health (NIH)-funded Microbicide Trials Network (MTN), will help determine if the gel should be evaluated further for its potential to prevent HIV among both men and women who engage in receptive anal intercourse.” View full resource at news-medical.net
Most Recently Shared on October 13, 2010 at 6:09 am By:
MTN-007 phase trial evaluates rectal safety of vaginal microbicide in HIV transmission: Tenofovir gel, a vaginal m... http://bit.ly/c4d8CR
Advertisement
